nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.118	0.248	CbGbCtD
Alfuzosin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0894	0.188	CbGbCtD
Alfuzosin—CYP3A4—Betamethasone—psoriatic arthritis	0.0767	0.161	CbGbCtD
Alfuzosin—CYP3A4—Prednisolone—psoriatic arthritis	0.0757	0.159	CbGbCtD
Alfuzosin—CYP3A4—Prednisone—psoriatic arthritis	0.0715	0.15	CbGbCtD
Alfuzosin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0446	0.0938	CbGbCtD
Alfuzosin—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00222	0.00423	CcSEcCtD
Alfuzosin—Pharyngitis—Triamcinolone—psoriatic arthritis	0.0022	0.0042	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.0022	0.00419	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.0022	0.00419	CcSEcCtD
Alfuzosin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00218	0.00415	CcSEcCtD
Alfuzosin—Osteoarthritis—Methotrexate—psoriatic arthritis	0.00212	0.00404	CcSEcCtD
Alfuzosin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00207	0.00395	CcSEcCtD
Alfuzosin—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00205	0.00392	CcSEcCtD
Alfuzosin—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00202	0.00385	CcSEcCtD
Alfuzosin—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00201	0.00383	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.002	0.00381	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00195	0.00372	CcSEcCtD
Alfuzosin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00194	0.0037	CcSEcCtD
Alfuzosin—Angioedema—Prednisolone—psoriatic arthritis	0.00192	0.00366	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00191	0.00365	CcSEcCtD
Alfuzosin—Breast disorder—Methotrexate—psoriatic arthritis	0.00191	0.00365	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00191	0.00364	CcSEcCtD
Alfuzosin—Malaise—Prednisolone—psoriatic arthritis	0.00189	0.00361	CcSEcCtD
Alfuzosin—Vertigo—Prednisolone—psoriatic arthritis	0.00189	0.0036	CcSEcCtD
Alfuzosin—Syncope—Prednisolone—psoriatic arthritis	0.00188	0.00359	CcSEcCtD
Alfuzosin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00188	0.00359	CcSEcCtD
Alfuzosin—Eye disorder—Betamethasone—psoriatic arthritis	0.00188	0.00359	CcSEcCtD
Alfuzosin—Back pain—Triamcinolone—psoriatic arthritis	0.00187	0.00356	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00185	0.00352	CcSEcCtD
Alfuzosin—Angiopathy—Betamethasone—psoriatic arthritis	0.00183	0.00348	CcSEcCtD
Alfuzosin—Angiopathy—Dexamethasone—psoriatic arthritis	0.00183	0.00348	CcSEcCtD
Alfuzosin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00179	0.00342	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00179	0.00341	CcSEcCtD
Alfuzosin—Discomfort—Prednisolone—psoriatic arthritis	0.00177	0.00337	CcSEcCtD
Alfuzosin—Angioedema—Triamcinolone—psoriatic arthritis	0.00176	0.00337	CcSEcCtD
Alfuzosin—Angioedema—Methylprednisolone—psoriatic arthritis	0.00176	0.00336	CcSEcCtD
Alfuzosin—Malaise—Triamcinolone—psoriatic arthritis	0.00174	0.00332	CcSEcCtD
Alfuzosin—Malaise—Methylprednisolone—psoriatic arthritis	0.00174	0.00331	CcSEcCtD
Alfuzosin—Vertigo—Triamcinolone—psoriatic arthritis	0.00174	0.00331	CcSEcCtD
Alfuzosin—Syncope—Triamcinolone—psoriatic arthritis	0.00173	0.0033	CcSEcCtD
Alfuzosin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00173	0.0033	CcSEcCtD
Alfuzosin—Syncope—Methylprednisolone—psoriatic arthritis	0.00173	0.0033	CcSEcCtD
Alfuzosin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00172	0.00329	CcSEcCtD
Alfuzosin—Oedema—Prednisolone—psoriatic arthritis	0.00171	0.00327	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.0017	0.00324	CcSEcCtD
Alfuzosin—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.0017	0.00324	CcSEcCtD
Alfuzosin—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00169	0.00323	CcSEcCtD
Alfuzosin—Shock—Prednisolone—psoriatic arthritis	0.00169	0.00322	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00169	0.00322	CcSEcCtD
Alfuzosin—Tachycardia—Prednisolone—psoriatic arthritis	0.00167	0.00319	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00166	0.00316	CcSEcCtD
Alfuzosin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00164	0.00313	CcSEcCtD
Alfuzosin—Eye disorder—Prednisone—psoriatic arthritis	0.00164	0.00312	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—psoriatic arthritis	0.00163	0.00311	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—psoriatic arthritis	0.00163	0.00311	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—psoriatic arthritis	0.00163	0.00311	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00163	0.00311	CcSEcCtD
Alfuzosin—Flushing—Prednisone—psoriatic arthritis	0.00163	0.0031	CcSEcCtD
Alfuzosin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00163	0.0031	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00163	0.0031	CcSEcCtD
Alfuzosin—Discomfort—Triamcinolone—psoriatic arthritis	0.00162	0.0031	CcSEcCtD
Alfuzosin—Discomfort—Methylprednisolone—psoriatic arthritis	0.00162	0.00309	CcSEcCtD
Alfuzosin—Dry mouth—Triamcinolone—psoriatic arthritis	0.00161	0.00307	CcSEcCtD
Alfuzosin—Angioedema—Betamethasone—psoriatic arthritis	0.0016	0.00305	CcSEcCtD
Alfuzosin—Angioedema—Dexamethasone—psoriatic arthritis	0.0016	0.00305	CcSEcCtD
Alfuzosin—Angiopathy—Prednisone—psoriatic arthritis	0.00159	0.00303	CcSEcCtD
Alfuzosin—Malaise—Dexamethasone—psoriatic arthritis	0.00158	0.00301	CcSEcCtD
Alfuzosin—Malaise—Betamethasone—psoriatic arthritis	0.00158	0.00301	CcSEcCtD
Alfuzosin—Oedema—Triamcinolone—psoriatic arthritis	0.00158	0.00301	CcSEcCtD
Alfuzosin—Vertigo—Dexamethasone—psoriatic arthritis	0.00157	0.003	CcSEcCtD
Alfuzosin—Vertigo—Betamethasone—psoriatic arthritis	0.00157	0.003	CcSEcCtD
Alfuzosin—Syncope—Betamethasone—psoriatic arthritis	0.00157	0.003	CcSEcCtD
Alfuzosin—Syncope—Dexamethasone—psoriatic arthritis	0.00157	0.003	CcSEcCtD
Alfuzosin—Infection—Triamcinolone—psoriatic arthritis	0.00157	0.00299	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—psoriatic arthritis	0.00156	0.00298	CcSEcCtD
Alfuzosin—Infection—Methylprednisolone—psoriatic arthritis	0.00156	0.00298	CcSEcCtD
Alfuzosin—Shock—Triamcinolone—psoriatic arthritis	0.00155	0.00296	CcSEcCtD
Alfuzosin—Shock—Methylprednisolone—psoriatic arthritis	0.00155	0.00295	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00154	0.00294	CcSEcCtD
Alfuzosin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00154	0.00294	CcSEcCtD
Alfuzosin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00154	0.00294	CcSEcCtD
Alfuzosin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00154	0.00294	CcSEcCtD
Alfuzosin—Tachycardia—Triamcinolone—psoriatic arthritis	0.00154	0.00293	CcSEcCtD
Alfuzosin—Mental disorder—Prednisone—psoriatic arthritis	0.00154	0.00293	CcSEcCtD
Alfuzosin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00153	0.00293	CcSEcCtD
Alfuzosin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00153	0.00291	CcSEcCtD
Alfuzosin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00152	0.00291	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00152	0.0029	CcSEcCtD
Alfuzosin—Discomfort—Dexamethasone—psoriatic arthritis	0.00147	0.00281	CcSEcCtD
Alfuzosin—Discomfort—Betamethasone—psoriatic arthritis	0.00147	0.00281	CcSEcCtD
Alfuzosin—Hypotension—Methylprednisolone—psoriatic arthritis	0.00147	0.0028	CcSEcCtD
Alfuzosin—Pain—Prednisolone—psoriatic arthritis	0.00147	0.0028	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—psoriatic arthritis	0.00145	0.00277	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00145	0.00276	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—psoriatic arthritis	0.00144	0.00274	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00144	0.00274	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00143	0.00273	CcSEcCtD
Alfuzosin—Oedema—Dexamethasone—psoriatic arthritis	0.00143	0.00273	CcSEcCtD
Alfuzosin—Oedema—Betamethasone—psoriatic arthritis	0.00143	0.00273	CcSEcCtD
Alfuzosin—Infection—Betamethasone—psoriatic arthritis	0.00142	0.00271	CcSEcCtD
Alfuzosin—Infection—Dexamethasone—psoriatic arthritis	0.00142	0.00271	CcSEcCtD
Alfuzosin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00142	0.0027	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00141	0.00269	CcSEcCtD
Alfuzosin—Shock—Dexamethasone—psoriatic arthritis	0.00141	0.00268	CcSEcCtD
Alfuzosin—Shock—Betamethasone—psoriatic arthritis	0.00141	0.00268	CcSEcCtD
Alfuzosin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.0014	0.00268	CcSEcCtD
Alfuzosin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.0014	0.00268	CcSEcCtD
Alfuzosin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0014	0.00267	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0014	0.00267	CcSEcCtD
Alfuzosin—Tachycardia—Betamethasone—psoriatic arthritis	0.0014	0.00266	CcSEcCtD
Alfuzosin—Tachycardia—Dexamethasone—psoriatic arthritis	0.0014	0.00266	CcSEcCtD
Alfuzosin—Angioedema—Prednisone—psoriatic arthritis	0.00139	0.00266	CcSEcCtD
Alfuzosin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00139	0.00265	CcSEcCtD
Alfuzosin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00138	0.00264	CcSEcCtD
Alfuzosin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00138	0.00264	CcSEcCtD
Alfuzosin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00138	0.00264	CcSEcCtD
Alfuzosin—Malaise—Prednisone—psoriatic arthritis	0.00138	0.00262	CcSEcCtD
Alfuzosin—Vertigo—Prednisone—psoriatic arthritis	0.00137	0.00262	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—psoriatic arthritis	0.00137	0.00261	CcSEcCtD
Alfuzosin—Syncope—Prednisone—psoriatic arthritis	0.00137	0.00261	CcSEcCtD
Alfuzosin—Urticaria—Prednisolone—psoriatic arthritis	0.00136	0.0026	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00136	0.00259	CcSEcCtD
Alfuzosin—Fatigue—Triamcinolone—psoriatic arthritis	0.00136	0.00259	CcSEcCtD
Alfuzosin—Fatigue—Methylprednisolone—psoriatic arthritis	0.00136	0.00259	CcSEcCtD
Alfuzosin—Pain—Triamcinolone—psoriatic arthritis	0.00135	0.00257	CcSEcCtD
Alfuzosin—Loss of consciousness—Prednisone—psoriatic arthritis	0.00134	0.00256	CcSEcCtD
Alfuzosin—Hypotension—Dexamethasone—psoriatic arthritis	0.00134	0.00255	CcSEcCtD
Alfuzosin—Hypotension—Betamethasone—psoriatic arthritis	0.00134	0.00255	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—psoriatic arthritis	0.00133	0.00254	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00132	0.00252	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0013	0.00249	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0013	0.00249	CcSEcCtD
Alfuzosin—Arthralgia—Prednisone—psoriatic arthritis	0.0013	0.00248	CcSEcCtD
Alfuzosin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.0013	0.00248	CcSEcCtD
Alfuzosin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.0013	0.00247	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00129	0.00246	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00129	0.00245	CcSEcCtD
Alfuzosin—Discomfort—Prednisone—psoriatic arthritis	0.00128	0.00245	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—psoriatic arthritis	0.00128	0.00245	CcSEcCtD
Alfuzosin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00126	0.0024	CcSEcCtD
Alfuzosin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00126	0.0024	CcSEcCtD
Alfuzosin—Urticaria—Triamcinolone—psoriatic arthritis	0.00125	0.00239	CcSEcCtD
Alfuzosin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00125	0.00238	CcSEcCtD
Alfuzosin—Oedema—Prednisone—psoriatic arthritis	0.00125	0.00238	CcSEcCtD
Alfuzosin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00124	0.00237	CcSEcCtD
Alfuzosin—Infection—Prednisone—psoriatic arthritis	0.00124	0.00236	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00123	0.00236	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00123	0.00236	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—psoriatic arthritis	0.00123	0.00235	CcSEcCtD
Alfuzosin—Fatigue—Betamethasone—psoriatic arthritis	0.00123	0.00235	CcSEcCtD
Alfuzosin—Fatigue—Dexamethasone—psoriatic arthritis	0.00123	0.00235	CcSEcCtD
Alfuzosin—Shock—Prednisone—psoriatic arthritis	0.00123	0.00234	CcSEcCtD
Alfuzosin—Pain—Betamethasone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Alfuzosin—Pain—Dexamethasone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Alfuzosin—Nervous system disorder—Prednisone—psoriatic arthritis	0.00122	0.00233	CcSEcCtD
Alfuzosin—Tachycardia—Prednisone—psoriatic arthritis	0.00122	0.00232	CcSEcCtD
Alfuzosin—Skin disorder—Prednisone—psoriatic arthritis	0.00121	0.00231	CcSEcCtD
Alfuzosin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.0012	0.0023	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00118	0.00226	CcSEcCtD
Alfuzosin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00118	0.00225	CcSEcCtD
Alfuzosin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00118	0.00225	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00117	0.00223	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00117	0.00223	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—psoriatic arthritis	0.00115	0.00219	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—psoriatic arthritis	0.00115	0.00219	CcSEcCtD
Alfuzosin—Urticaria—Betamethasone—psoriatic arthritis	0.00114	0.00217	CcSEcCtD
Alfuzosin—Urticaria—Dexamethasone—psoriatic arthritis	0.00114	0.00217	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Alfuzosin—Dizziness—Prednisolone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Alfuzosin—Asthenia—Triamcinolone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Alfuzosin—Abdominal pain—Betamethasone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Alfuzosin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00113	0.00216	CcSEcCtD
Alfuzosin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00113	0.00215	CcSEcCtD
Alfuzosin—Pruritus—Triamcinolone—psoriatic arthritis	0.00112	0.00213	CcSEcCtD
Alfuzosin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00111	0.00212	CcSEcCtD
Alfuzosin—Dyspepsia—Prednisone—psoriatic arthritis	0.0011	0.00209	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—psoriatic arthritis	0.00109	0.00207	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—psoriatic arthritis	0.00109	0.00207	CcSEcCtD
Alfuzosin—Rash—Prednisolone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Alfuzosin—Dermatitis—Prednisolone—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00108	0.00206	CcSEcCtD
Alfuzosin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00108	0.00205	CcSEcCtD
Alfuzosin—Fatigue—Prednisone—psoriatic arthritis	0.00107	0.00205	CcSEcCtD
Alfuzosin—Headache—Prednisolone—psoriatic arthritis	0.00107	0.00205	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—psoriatic arthritis	0.00107	0.00205	CcSEcCtD
Alfuzosin—Constipation—Prednisone—psoriatic arthritis	0.00107	0.00203	CcSEcCtD
Alfuzosin—Dizziness—Triamcinolone—psoriatic arthritis	0.00104	0.00199	CcSEcCtD
Alfuzosin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00104	0.00198	CcSEcCtD
Alfuzosin—Infection—Methotrexate—psoriatic arthritis	0.00103	0.00197	CcSEcCtD
Alfuzosin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00103	0.00196	CcSEcCtD
Alfuzosin—Asthenia—Betamethasone—psoriatic arthritis	0.00103	0.00196	CcSEcCtD
Alfuzosin—Asthenia—Dexamethasone—psoriatic arthritis	0.00103	0.00196	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00102	0.00195	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00102	0.00194	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00102	0.00194	CcSEcCtD
Alfuzosin—Nausea—Prednisolone—psoriatic arthritis	0.00102	0.00194	CcSEcCtD
Alfuzosin—Pruritus—Dexamethasone—psoriatic arthritis	0.00101	0.00193	CcSEcCtD
Alfuzosin—Pruritus—Betamethasone—psoriatic arthritis	0.00101	0.00193	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—psoriatic arthritis	0.00101	0.00193	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00101	0.00192	CcSEcCtD
Alfuzosin—Vomiting—Triamcinolone—psoriatic arthritis	0.001	0.00191	CcSEcCtD
Alfuzosin—Vomiting—Methylprednisolone—psoriatic arthritis	0.001	0.00191	CcSEcCtD
Alfuzosin—Rash—Triamcinolone—psoriatic arthritis	0.000994	0.0019	CcSEcCtD
Alfuzosin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000993	0.00189	CcSEcCtD
Alfuzosin—Rash—Methylprednisolone—psoriatic arthritis	0.000992	0.00189	CcSEcCtD
Alfuzosin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000991	0.00189	CcSEcCtD
Alfuzosin—Urticaria—Prednisone—psoriatic arthritis	0.000989	0.00189	CcSEcCtD
Alfuzosin—Headache—Triamcinolone—psoriatic arthritis	0.000987	0.00188	CcSEcCtD
Alfuzosin—Headache—Methylprednisolone—psoriatic arthritis	0.000985	0.00188	CcSEcCtD
Alfuzosin—Abdominal pain—Prednisone—psoriatic arthritis	0.000985	0.00188	CcSEcCtD
Alfuzosin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000979	0.00187	CcSEcCtD
Alfuzosin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000979	0.00187	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—psoriatic arthritis	0.000973	0.00186	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000948	0.00181	CcSEcCtD
Alfuzosin—Dizziness—Dexamethasone—psoriatic arthritis	0.000946	0.0018	CcSEcCtD
Alfuzosin—Dizziness—Betamethasone—psoriatic arthritis	0.000946	0.0018	CcSEcCtD
Alfuzosin—Nausea—Triamcinolone—psoriatic arthritis	0.000936	0.00179	CcSEcCtD
Alfuzosin—Nausea—Methylprednisolone—psoriatic arthritis	0.000934	0.00178	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—psoriatic arthritis	0.000925	0.00177	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000916	0.00175	CcSEcCtD
Alfuzosin—Vomiting—Betamethasone—psoriatic arthritis	0.000909	0.00173	CcSEcCtD
Alfuzosin—Vomiting—Dexamethasone—psoriatic arthritis	0.000909	0.00173	CcSEcCtD
Alfuzosin—Rash—Betamethasone—psoriatic arthritis	0.000902	0.00172	CcSEcCtD
Alfuzosin—Rash—Dexamethasone—psoriatic arthritis	0.000902	0.00172	CcSEcCtD
Alfuzosin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000901	0.00172	CcSEcCtD
Alfuzosin—Dermatitis—Betamethasone—psoriatic arthritis	0.000901	0.00172	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000899	0.00171	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—psoriatic arthritis	0.000897	0.00171	CcSEcCtD
Alfuzosin—Headache—Dexamethasone—psoriatic arthritis	0.000896	0.00171	CcSEcCtD
Alfuzosin—Headache—Betamethasone—psoriatic arthritis	0.000896	0.00171	CcSEcCtD
Alfuzosin—Asthenia—Prednisone—psoriatic arthritis	0.000894	0.0017	CcSEcCtD
Alfuzosin—Pain—Methotrexate—psoriatic arthritis	0.00089	0.0017	CcSEcCtD
Alfuzosin—Pruritus—Prednisone—psoriatic arthritis	0.000881	0.00168	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000858	0.00164	CcSEcCtD
Alfuzosin—Diarrhoea—Prednisone—psoriatic arthritis	0.000852	0.00163	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000851	0.00162	CcSEcCtD
Alfuzosin—Nausea—Dexamethasone—psoriatic arthritis	0.00085	0.00162	CcSEcCtD
Alfuzosin—Nausea—Betamethasone—psoriatic arthritis	0.00085	0.00162	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—psoriatic arthritis	0.000827	0.00158	CcSEcCtD
Alfuzosin—Dizziness—Prednisone—psoriatic arthritis	0.000824	0.00157	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000823	0.00157	CcSEcCtD
Alfuzosin—Vomiting—Prednisone—psoriatic arthritis	0.000792	0.00151	CcSEcCtD
Alfuzosin—Rash—Prednisone—psoriatic arthritis	0.000785	0.0015	CcSEcCtD
Alfuzosin—Dermatitis—Prednisone—psoriatic arthritis	0.000785	0.0015	CcSEcCtD
Alfuzosin—Headache—Prednisone—psoriatic arthritis	0.00078	0.00149	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—psoriatic arthritis	0.000747	0.00142	CcSEcCtD
Alfuzosin—Nausea—Prednisone—psoriatic arthritis	0.00074	0.00141	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—psoriatic arthritis	0.000736	0.0014	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000712	0.00136	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—psoriatic arthritis	0.000688	0.00131	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—psoriatic arthritis	0.000662	0.00126	CcSEcCtD
Alfuzosin—Rash—Methotrexate—psoriatic arthritis	0.000656	0.00125	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—psoriatic arthritis	0.000656	0.00125	CcSEcCtD
Alfuzosin—Headache—Methotrexate—psoriatic arthritis	0.000652	0.00124	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—psoriatic arthritis	0.000618	0.00118	CcSEcCtD
